January 20, 2009
Debra Milasincic, Ph.D. and Amy Mandragouras delivered this presentation to the Massachusetts Biotechnology Council's Project Management Committee on January 20, 2009. It provides an overview of Freedom to Operate (FTO), including what, why, when, and how.
For more information, please contact Debra at dmilasincic@lahive.com or Amy at amandragouras@lahive.com.
The client, a software developer that creates unique software for modeling dynamic systems, wanted to protect its flagship product. That product, used for three-dimensional modeling and simulation, has been a huge commercial success, particularly in the automotive sector. » read more
USPTO and the Federal Service for Intellectual Property, Patents and Trademarks of the Russian Federation (ROSPATENT) Launch Patent Prosecution Highway Pilot Program on September 1 » read more
Giulio A. DeConti Selected to Best Lawyers in America » read more
CAFC Invalidates Patent Covering Methods of Using Gemzar » read more
December 2, 2010
Peter Dini presents "Antibodies: Overcoming Patentability Hurdles and Claim Drafting Strategies for New Technological Developments" at the ACI Biotech Patents Conference » read more
August 30, 2010
James Velema and Peter Dini present "Patenting of Therapeutic Antibodies" to the NRC Biotechnology Research Institute, Montreal, Canada » read more
August 26, 2010
Brian Trinque presents "Nonobviousness of Chemical Inventions" at 240th ACS National Meeting » read more
Web Site Developed by 